Wall Street analysts forecast that ICU Medical, Incorporated (NASDAQ:ICUI) will report earnings per share of $2.18 for the current quarter, according to Zacks. Two analysts have made estimates for ICU Medical’s earnings. The highest EPS estimate is $2.23 and the lowest is $2.12. ICU Medical reported earnings per share of $2.26 in the same quarter last year, which suggests a negative year over year growth rate of 3.5%. The company is expected to announce its next earnings report on Wednesday, May 8th.
According to Zacks, analysts expect that ICU Medical will report full-year earnings of $9.44 per share for the current year, with EPS estimates ranging from $9.43 to $9.45. For the next fiscal year, analysts expect that the firm will post earnings of $10.27 per share. Zacks’ EPS averages are an average based on a survey of analysts that cover ICU Medical.
Several equities research analysts have recently commented on the company. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, February 20th. Raymond James cut their price target on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research note on Friday, March 1st. TheStreet cut ICU Medical from a “b-” rating to a “c+” rating in a research note on Tuesday, March 19th. Finally, Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 price target for the company in a research note on Thursday, March 7th. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $281.00.
In other ICU Medical news, Director Robert S. Swinney sold 1,500 shares of the firm’s stock in a transaction dated Monday, January 28th. The stock was sold at an average price of $242.19, for a total value of $363,285.00. Following the sale, the director now directly owns 19,540 shares of the company’s stock, valued at approximately $4,732,392.60. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Virginia Ruth Sanzone sold 5,277 shares of the firm’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $232.31, for a total value of $1,225,899.87. Following the completion of the sale, the vice president now directly owns 13,167 shares in the company, valued at $3,058,825.77. The disclosure for this sale can be found here. Insiders sold 8,241 shares of company stock valued at $1,932,712 in the last quarter. 12.50% of the stock is currently owned by company insiders.
A number of large investors have recently modified their holdings of ICUI. AQR Capital Management LLC raised its holdings in shares of ICU Medical by 566.3% in the 3rd quarter. AQR Capital Management LLC now owns 382,179 shares of the medical instruments supplier’s stock worth $108,061,000 after purchasing an additional 324,819 shares during the period. FMR LLC raised its holdings in shares of ICU Medical by 91.1% in the 4th quarter. FMR LLC now owns 417,787 shares of the medical instruments supplier’s stock worth $95,937,000 after purchasing an additional 199,185 shares during the period. Norges Bank purchased a new position in shares of ICU Medical in the 4th quarter worth about $41,575,000. Partner Fund Management L.P. purchased a new position in shares of ICU Medical in the 4th quarter worth about $40,359,000. Finally, American Century Companies Inc. raised its holdings in shares of ICU Medical by 175.6% in the 4th quarter. American Century Companies Inc. now owns 252,304 shares of the medical instruments supplier’s stock worth $57,937,000 after purchasing an additional 160,768 shares during the period. 93.29% of the stock is currently owned by hedge funds and other institutional investors.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Featured Article: What Is An Exchange-Traded Fund (ETF)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.